Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
0.8600
+0.0100 (1.18%)
At close: Aug 13, 2025, 4:00 PM
0.9033
+0.0833 (10.16%)
Pre-market: Aug 14, 2025, 4:16 AM EDT
Dyadic International Market Cap
Dyadic International has a market cap or net worth of $31.12 million as of August 14, 2025. Its market cap has decreased by -25.55% in one year.
Market Cap
31.12M
Enterprise Value
29.75M
1-Year Change
-25.55%
Ranking
Category
Stock Price
$0.86
Market Cap Chart
Since April 18, 2019, Dyadic International's market cap has decreased from $94.80M to $31.12M, a decrease of -67.17%. That is a compound annual growth rate of -16.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 24.70M | -52.32% |
| Dec 31, 2024 | 51.80M | 11.64% |
| Dec 29, 2023 | 46.40M | 32.19% |
| Dec 30, 2022 | 35.10M | -72.34% |
| Dec 31, 2021 | 126.90M | -14.20% |
| Dec 31, 2020 | 147.90M | 4.89% |
| Dec 31, 2019 | 141.00M | 48.73% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |